1007-3418
2015 Issue 10
Management of liver failure by a multidisciplinary team approach
Dong Xuyang;,Zhou Xinmin;
Dong Xuyang;,Zhou Xinmin;
..............page:721-723
Diagnosis of and multimodality therapy for hepatorenal syndrome
Guo Xiaozhong;,Zhang Yongguo;
Guo Xiaozhong;,Zhang Yongguo;
..............page:724-726
Diagnosis and multimodality therapy for non-alcoholic fatty liver disease
Sun Wenjing;,Chen Dongfeng;
Sun Wenjing;,Chen Dongfeng;
..............page:727-729
Perspectives on the multidisciplinary treatment approach for hepatocellular carcinoma
Lu Wei;,Zhang Ningning;
Lu Wei;,Zhang Ningning;
..............page:730-732
A randomized controlled trial on 240-week monotherapy with entecavir or adefovir in patients with chronic hepatitis B and cirrhosis
Lian Jia;,Han Tao;,Xiang Huiling;,Liu Fang;,Lyu Hongmin;,Gao Yanying;,Wang Fengmei;
Lian Jia;,Han Tao;,Xiang Huiling;,Liu Fang;,Lyu Hongmin;,Gao Yanying;,Wang Fengmei;
..............page:733-737
Diagnostic value of FibroTest for liver fibrosis in patients with chronic hepatitis B
Wang Chunyan;,Cheng Xiaojing;,Meng Chao;,Lu Wei;
Wang Chunyan;,Cheng Xiaojing;,Meng Chao;,Lu Wei;
..............page:738-741
Imaging features of factors related to blood supply from right inferior hepatic artery branches in hepatocellular carcinoma
Wang Yuxi;,Luo Xiaoping;,Liu Xi;,He Mingju;,Yang Wei;
Wang Yuxi;,Luo Xiaoping;,Liu Xi;,He Mingju;,Yang Wei;
..............page:742-747
Regulatory role of serum miR-224 in invasiveness and metastasis of cholangiocarcinoma
huang min dan ;, wu xiong bo ;, cao hui ;, zhan qiang ;, xia min ;, zhou qun yan ;, cai xiao gang ;, an fang mei ;
huang min dan ;, wu xiong bo ;, cao hui ;, zhan qiang ;, xia min ;, zhou qun yan ;, cai xiao gang ;, an fang mei ;
..............page:748-753
..............page:753,759,777
Body mass index is a risk factor for new-onset non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
Wang Shan;,Zhang Hailing;,Tong Bo;,Wang Qian;,Zhang Yanmin;,Zhu Guoling;,Wu Shouling;
Wang Shan;,Zhang Hailing;,Tong Bo;,Wang Qian;,Zhang Yanmin;,Zhu Guoling;,Wu Shouling;
..............page:754-759
Relationship of socioeconomic status and non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus
Jia Guoyu;,Li Xuefen;,Wang Lu;,Li Qiang;,Yang Li;,Li Nali;,Di Fusheng;
Jia Guoyu;,Li Xuefen;,Wang Lu;,Li Qiang;,Yang Li;,Li Nali;,Di Fusheng;
..............page:760-764
Role of the Notch signaling pathway in development of acute liver failure in a mouse model
Cao Wei;,Zhao Caiyan;,Wang Wei;,Zhao Xin;,Su Miao;,Wang Yadong;,Shen Chuan;
Cao Wei;,Zhao Caiyan;,Wang Wei;,Zhao Xin;,Su Miao;,Wang Yadong;,Shen Chuan;
..............page:765-770
Role of SREBP-1c in risk of liver disease associated with the triacylglycerol lipase PNPLA3 I148M variant
huang hai yan ;, an bai quan ;, xin yong ning ;, jiang man ;, jin wen wen ;, lin zhong hua ;, jiang xiang jun ;, xuan shi ying ;
huang hai yan ;, an bai quan ;, xin yong ning ;, jiang man ;, jin wen wen ;, lin zhong hua ;, jiang xiang jun ;, xuan shi ying ;
..............page:771-774
Retrospective study on efficacy and safety of the sequential use of a non-bioartificial liver support system in the treatment of acute fatty liver during pregnancy
he na ;, zhao long bin ;, zheng yang yang ;, zhu shao hua ;, zhang jing ;, li na ;, xia lin ;, yin fang ;, zhou xin min ;
he na ;, zhao long bin ;, zheng yang yang ;, zhu shao hua ;, zhang jing ;, li na ;, xia lin ;, yin fang ;, zhou xin min ;
..............page:775-777
Expression of cannabinoid receptors in hepatic stellate cells of patients with chronic hepatitis B and significance for progression of liver fibrosis
Dai Erhei;,Wan Shiqing;,Ye Lihong;,Feng Lulu;,Wang Kun;,Zhang Lianshan;
Dai Erhei;,Wan Shiqing;,Ye Lihong;,Feng Lulu;,Wang Kun;,Zhang Lianshan;
..............page:778-780
Antitumor activity of siRNAs targeting ALCAM in HepG2 liver cancer cells in vitro and in vivo
Zhong Li;,Gou Juhua;,Deng Nian;,Shen Hao;,Zhang Bingqiang;
Zhong Li;,Gou Juhua;,Deng Nian;,Shen Hao;,Zhang Bingqiang;
..............page:781-783
Apoptosis-stimulating protein of p53 (ASPP2) inhibits tumor growth
Liang Beibei;,Xue Bangde;,Gao Meilian;,Wang Hongzhi;
Liang Beibei;,Xue Bangde;,Gao Meilian;,Wang Hongzhi;
..............page:784-786
A case report of immune thrombocytopenia with drug induced liver disease
Fang Guoping;,Qian Meiyun;,Zhai Defang;,Feng Quangen;,Su Jiannong;,Cao Qi;,Ma Bo;
Fang Guoping;,Qian Meiyun;,Zhai Defang;,Feng Quangen;,Su Jiannong;,Cao Qi;,Ma Bo;
..............page:786-787
Brief introduction of 2015 international symposium: autoimmune diseases in the liver
Yan Huiping;,Liu Yanmin;,Zhang Haiping;
Yan Huiping;,Liu Yanmin;,Zhang Haiping;
..............page:788-790
Self-regulation of the renin-angiotensin system and liver fibrosis:clinical implications
Jia Xiufeng;,Xie Jiwen;,Zhu Rui;,Wu Lin;,Chen Xi;,Zeng Yuyang;
Jia Xiufeng;,Xie Jiwen;,Zhu Rui;,Wu Lin;,Chen Xi;,Zeng Yuyang;
..............page:791-793
Role of extracellular histones in liver failure
Zhang Xueqing;,Lin Su;
Zhang Xueqing;,Lin Su;
..............page:794-796
Clinical significance of abnormal Wnt signaling pathway expression in hepatitis and hepatocellular carcinoma
Pan Liuhong;,Yao Min;,Yao Dengfu;
Pan Liuhong;,Yao Min;,Yao Dengfu;
..............page:797-800